Updated EU manufacturing guidelines are accelerating the adoption of pre-use post-sterilization integrity testing to verify filter reliability before biopharmaceutical production begins. This methodology is vital for tech professionals in the sector as it identifies potential defects that might otherwise be masked during the filtration process itself. The shift toward automated single-use systems highlights a broader industry trend of integrating real-time quality control into digitized manufacturing pipelines.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
14
Tags
Ali NematiWritten by Ali
